•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.S&P 500 Edges Lower; RH Shares Plunge After Q1 Results
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gold Gains 1%; US Consumer Sentiment Falls In June
Dow Tumbles Over 200 Points; Adobe Earnings Top Views
Gain Therapeutics shares slide on pricing public offering of units to raise $11M
Gain Therapeutics Announces Pricing of $11.0 Million Public Offering
Gain Therapeutics Announces Pricing of $11.0 Million Public Offering
Gain Therapeutics Shares Drop 14% After Proposed Public Offering News
Gain Therapeutics Announces Proposed Public Offering
Gain Therapeutics shares fall on proposed public offering
Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Poster Presentation at Federation of European Neuroscience Societies (FENS) Forum 2024
Buy Rating Affirmed for Gain Therapeutics Amidst Promising Clinical Trials and Strong Financial Health
Buy Rating Affirmed for Gain Therapeutics Amid Positive Clinical and Financial Performance
Adherex Technologies Inc. (FENC) Lags Q1 Earnings Estimates
Will Gain Therapeutics, Inc. (GANX) Report Negative Q1 Earnings? What You Should Know
Buy Rating Affirmed for Gain Therapeutics on Promising GT-02287 Clinical Progress
Gain Therapeutics Shares Rise 8% After Positive Results From Early Trial of Parkinson's Disease Therapy
Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.